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Early detection of many fetal abnormalities is now possible due to the availability 
of antenatal ultrasound screening in the 12th to 16th week of gestation. Regarding 
urinary tract anomalies, most can be detected at 18–20 weeks of gestation. The 
incidence of antenatal hydronephrosis is 0.6–4.5%, and it makes up about 92% 
of antenatally-detected urinary tract anomalies. If antenatal hydronephrosis is 
detected, the patient should be carefully followed-up in order to identify the associ-
ated congenital anomaly. Usually, if the renal pelvic diameter exceeds 5 mm in the 
second trimester, then fetal ultrasonography should be repeated in the third trimester. 
Renal pelvic diameter greater then 7 mm is often related to a significant congenital 
anomaly; therefore, a plan for management after birth should be detailed. The new-
born should be treated with prophylactic antibiotics and investigative imaging stud-
ies should be arranged accordingly.
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The term antenatal hydronephrosis, fetal hydronephro-
sis or prenatal hydronephrosis refers to dilatation of the 
renal pelvis collecting system, which is a common find-
ing on antenatal ultrasound examinations in 0.6–4.5% of 
pregnancies.1 Differences in reported data may be due 
to different criteria used to define the disorder and the 
level of attention paid to the urinary system by the ultra-
sonographer.2–7 It is bilateral in 20–40% of cases,8 and 
occurs approximately twice as often in males than in 
females. About 3 million maternal ultrasounds in the 
United States are performed annually, with hydroneph-
rosis being the most commonly detected anomaly. As 
the routine use of maternal ultrasound has become 
more prevalent, urologists and pediatricians are increas-
ingly being informed about possible kidney defects be-
fore birth. Urinary tract anomalies can be detected as 
early as the 12th to 14th week of gestation.9 On the other 
hand, they may not be detected until later in infancy or 
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childhood when symptoms of urinary tract infection or 
obstruction develop.
The majority of fetuses found to have renal pelvic 
dilatation are in a transient physiologic state; the anom-
aly is not clinically significant and usually resolves spon-
taneously. However, obstruction or reflux can prevent 
normal renal development and lead to progressive dete-
rioration of renal function in some cases. The goal of an-
tenatal ultrasound screening and postnatal management 
is to detect these congenital anomalies that may other-
wise impact the health of the infant and that require fur-
ther evaluation and possible intervention to improve 
outcomes.
2.  Definition and Grading
The diagnostic criteria are still controversial. Several 
systems have been developed to grade the severity of 
antenatal hydronephrosis.
Y.C. Chen, et al
110 Vol. 21, 109–112, September 2010
2.1.  Society for Fetal Urology
The Society for Fetal Urology10 uses a grading system 
(grades 0–4) based on the degree of pelvic dilation, 
presence of caliceal dilation, and the presence and se-
verity of parenchymal thinning or atrophy, as listed in 
Table 1.
2.2.  Anterior–posterior diameter
The anterior–posterior diameter (APD) of the renal pel-
vis is the most common classification for reporting ante-
natal hydronephrosis. It is based on the measurement of 
the maximum anteroposterior diameter of the renal pel-
vis, or the renal pelvic diameter and gestational age.11 
Although there is a lack of consensus on the threshold 
of APD that defines the severity of antenatal hydroneph-
rosis, most experts now agree that hydronephrosis is 
clinically significant when APD exceeds 5 mm before 
24 weeks of gestation or exceeds 7 mm beyond 25 weeks 
of gestation.2,12–16 The grading system according to the 
APD is shown in Table 2.
3.  Differential Diagnoses
The differential diagnoses of fetal hydronephrosis include 
physiologic hydronephrosis, ureteropelvic junction ob-
struction, ureterovesical pathology, and bladder outlet 
obstruction (Table 3).17
4.  Management
Postnatal evaluation includes detailed physical examina-
tion and the use of radiological studies to detect urinary 
tract abnormalities such as obstructive uropathy or vesi-
coureteral reflux (VUR).
Currently, there is no single test or finding that can 
accurately differentiate between infants with significant 
disease and those who are normal or have insignificant 
findings. In general, most experts recommend the use of 
an algorithm based on the presence of predictive factors 
such as bilateral involvement or severity of hydroneph-
rosis for postnatal management that limits unnecessary 
radiographic studies and minimizes parental distress.
4.1.  Physical examination
At birth, a complete physical examination of the newborn 
can detect abnormalities that suggest genitourinary 
abnormalities (Table 4).
4.2.  Imaging studies
Postnatal radiological evaluation of a newborn with 
antenatal hydronephrosis begins with an ultrasound 
Table 1  Society for Fetal Urology (SFU) grading system for 
infant hydronephrosis
Grade Pattern of renal sinus splitting
0 No splitting
I Urine in pelvis barely splits sinus
II Urine fills intrarenal pelvis
III SFU Grade 2 and minor calyces uniformly dilated
  and parenchyma preserved
IV SFU Grade 3 and parenchyma thin
Table 2  Anterior–posterior diameter (APD) grading system 
for fetal hydronephrosis and association with post-
natal pathology
APD during APD during Grading of % with
second third antenatal postnatal
trimester trimester hydronephrosis pathology
(mm) (mm)
≤ 7 ≤ 9 Mild 12
7–10 9–15 Moderate 45
> 10 > 15 Severe 88
Table 3  Differential diagnoses of antegrade hydronephrosis
Differential diagnosis of antenatal hydronephrosis %
Transient hydronephrosis 48
Physiologic hydronephrosis 15
Ureteropelvic junction obstruction 11
Vesicoureteral reflux 4
Megaureter, obstructed or non-obstructed 4
Multicystic kidney 2
Ureterocele 2
Posterior urethral valves 1
Other problems to be considered
  Renal cystic disease
  Megacalicosis
  Retrocaval ureter
  Midureteral stricture
  Ectopic ureter
  Prune belly syndrome
  Urethral atresia
  Anterior urethral valves
  Cloacal abnormality
  Hydrocolpos
  Urachal cyst
  Ovarian cyst
  Bowel duplication
  Duodenal atresia
  Anterior meningocele
  Pelvic tumor
  Ureteral polyp
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examination. The timing of ultrasonography and the 
need for other studies depend on the severity of postna-
tal hydronephrosis and whether there is unilateral or 
bilateral renal involvement.
4.2.1.  Ultrasonography
The timing of the study depends on the severity of ante-
natal hydronephrosis. Ultrasound examination of the 
kidneys and bladder is usually performed 48 hours after 
birth. In general, the examination should be avoided in 
the first 2 days after birth as hydronephrosis may not be 
detected because of physiologic volume depletion and 
relative oligouria. However, infants with bilateral hy-
dronephrosis and those with a severe solitary hydrone-
phrotic kidney require urgent evaluation on the 1st 
postnatal day. Ultrasound examination should be repeated 
3 months later if the initial postnatal ultrasound is nor-
mal or shows only mild hydronephrosis.
4.2.2.  Voiding cystourethrogram
A voiding cystourethrogram (VCUG) is performed to de-
tect VUR and to evaluate the posterior urethra in boys. If 
hydronephrosis is present on the postnatal ultrasound, 
then VCUG should be performed, usually within 4 weeks 
in the majority of cases.18,19 However, it must be obtained 
within 48 hours of birth in any infant suspected to have 
posterior urethral valve or bladder outlet obstruction. 
Furthermore, VCUG is recommended in all patients with 
antenatal hydronephrosis, including those who experi-
enced resolution of hydronephrosis at birth, because 
14% of infants will still have VUR20 and 45% will have 
urinary tract abnormalities.21
4.2.3.  Diuretic renography
Diuretic renography is used to diagnose urinary tract 
obstruction in infants with persistent hydronephrosis, 
and is usually ordered after a VCUG has demonstrated 
no VUR.17 It is relatively noninvasive, performed at 4–6 
weeks of age, and gives quantitative data on function and 
drainage. The radionuclide of choice, which is injected 
intravenously, is 99mtechnetium mercaptoacetyltriglycine 
(MAG 3) due to its high initial renal uptake, although 
99mtechnetium diethyltriamine pentaacetic acid (DTPA) 
may also be used. The split renal function is assessed 
quantitatively and is useful as a baseline study. A differen-
tial function of less than 40%, or greater than a 5% de-
crease on serial studies, may be an indication for surgical 
repair. Other authors use values less than 35% or even as 
low as 25%. It is important to note that these calculations 
are very operator-dependent.
The washout curve indicates the extent of obstruction. 
In a dilated system, if washout occurs rapidly after diu-
retic administration (< 15 minutes), then the system is not 
obstructed. The system is considered obstructed if wash-
out is delayed beyond 20 minutes. If washout is between 
15 and 20 minutes, then the study is indeterminate. In 
patients with unilateral hydronephrosis, if the normal 
non-hydronephrotic kidney and hydronephrotic kidney 
both have equal function, then conservative manage-
ment without surgery is a safe option.
4.2.4.  Intravenous urogram
The combination of renal ultrasound and diuretic renog-
raphy has replaced intravenous urography as a technique 
to evaluate renal anatomy and function in infants. It may 
not reveal additional information in asymptomatic in-
fants and has the risk of radiation exposure.
4.3.  Prophylactic antibiotics
The role of prophylactic antibiotics in children with ante-
natal hydronephrosis remains controversial. Higher rates 
of urinary tract infections have been reported in children 
with prenatally diagnosed hydronephrosis compared to 
the general pediatric population.22 While it is believed 
that prophylactic antibiotics will prevent urinary tract in-
fections in children with VUR, it has yet to be proven.23 
Common medications used for prophylaxis in neonates 
include amoxicillin24 50 mg/day and cephalexin25 50 mg/
day. The antibiotics should be started after delivery until 
the diagnosis of VUR or obstructive uropathy has been 
excluded.
4.4.  Surgical intervention
Prenatal intervention for fetuses with antenatal hydrone-
phrosis is controversial and is limited by technical con-
siderations. Although the first successful decompression 
Table 4  Physical examination of the newborn
Finding May indicate…
Abdominal mass Enlarged kidney due to pelviureteric junction obstruction 
  or multicystic dysplastic kidneys
Palpable bladder or poor urine stream and dribbling Posterior urethral valves in a male infant
Deficient abdominal wall with undescended testes Prune belly syndrome
Abnormalities in the spine and lower limbs or patulous anus Neurogenic bladder
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for antenatal hydronephrosis was achieved with open 
fetal surgery by creating bilateral cutaneous ureterosto-
mies in a 21-week-old fetus,26 the neonate did not survive 
due to pulmonary complications. Fetal cystoscopic abla-
tion of posterior urethral valves,27 and open and laparo-
scopic vesicostomies have also been described, but they 
were associated with high rates of complications.28 Most 
fetal defects detected are best treated after birth. There 
is still a lack of data to show that fetal intervention im-
proves postnatal outcomes. In utero surgical intervention 
should be weighed carefully against the risk of malfor-
mation caused by progressive damage to the fetus, lead-
ing to death or severe morbidity. In addition, it is still a 
challenge to obtain an accurate diagnosis with current 
technology, and the fetus who cannot wait to be cor-
rected after birth usually has chromosomal or other 
major anomalies. The ethical issue should be discussed 
extensively before any decision is made, clinically or 
experimentally.
5.  Conclusion
Antenatal hydronephrosis is a commonly made diagno-
sis and results in parental anxiety throughout the preg-
nancy. Careful communication with the parents and a 
detailed management strategy based on the findings of 
antenatal and postnatal ultrasound is mandatory. Use of 
an evidence-based protocol in each institution will lead to 
better understanding of the natural history of antenatal 
hydronephrosis and contribute to state-of-the-art man-
agement for this disease entity.
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